Vivek Ra­maswamy strikes again, this time launch­ing a Bei­jing-based biotech play­er with a pipeline

An­oth­er day, an­oth­er start­up at Vivek Ra­maswamy’s Roivant. And this time he’s un­der­scor­ing the glob­al na­ture of the in­dus­try and his busi­ness strat­e­gy, as Chi­na’s biotech scene ex­plodes with fresh cash and some fa­mil­iar drugs.

This morn­ing Roivant un­veiled Sino­vant along with CITICPE, a Chi­nese pri­vate eq­ui­ty group. This com­pa­ny is based in Bei­jing and Shang­hai, and it’s been as­sem­bling an ex­ec­u­tive crew and pipeline for to­day’s an­nounce­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER